chiHEA-125-Ama

N/A

Report date: 2024/02/05 14:00:29

Base Information

Drug NamechiHEA-125-Ama

Drug Alias NamechiHEA-125-AmachiHEA125-Ama

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Linker > Non-cleavable linkerBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > Amanitin payloadBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)

Mechanisms of ActionEpithelial cell adhesion molecule inhibitors

TargetsEpithelial cell adhesion molecule

Therapy Area/IndicationsPancreatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesGerman Cancer Research Center (Dkfz)

China Registration ClassN/A

Develop Information

Active CompaniesGerman Cancer Research Center (Dkfz)

Inactive CompaniesN/A

Active IndicationsPancreatic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A